Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition

被引:24
作者
VanVugt, DA
Piercy, J
Farley, AE
Reid, RL
Rivest, S
机构
[1] QUEENS UNIV, DEPT PHYSIOL, KINGSTON, ON K7L 3N6, CANADA
[2] CHUL, RES CTR, MOL ENDOCRINOL LAB, QUEBEC CITY, PQ, CANADA
[3] UNIV LAVAL, QUEBEC CITY, PQ, CANADA
关键词
D O I
10.1210/en.138.6.2249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Corticotropin-releasing Factor (CRF) is an important inhibitory neuromodulator of GnRH/LH secretion, and mediates in part the inhibitory effects of stress on the hypothalamic-pituitary-gonadal axis. The purpose of the present study was to further investigate CRF's role in regulating LH secretion in primates. This was accomplished by examining LH secretion in ovariectomized rhesus monkeys (n = 7) following cortisol synthesis inhibition with metyrapone. Infusion of metyrapone (5 mg/kg per h) for 4 h decreased cortisol levels to less than 20% of controls while increasing ACTH approximately 10-fold. LH concentrations were not affected by this acute activation of the hypothalamic-corticotroph axis. In a second experiment, metyrapone was infused for 10 h before collecting serial blood samples every 15 min for 6 h. Although this protocol produced a sustained increase in ACTH, no apparent effect on pulsatile LH secretion compared with saline controls was observed. Mean LH (+/- SEM) levels calculated for consecutive 2-h increments were 87.6 +/- 9.2 (0-2 h) 82.1 +/- 5.5 (2-4 h), and 80.7 +/- 4.8 (4-6 h) ng/ml in saline pretreated animals compared with 83.6 +/- 4.9, 79.8 +/- 5.8, and 72.5 +/- 6.2 ng/ml, respectively, in metyrapone pretreated monkeys. The same regimen of metyrapone infusion increased CRF messenger RNA levels in the paraventricular nucleus by approximately 33% (P < 0.0002). In a final experiment designed to examine the potential synergy between CRF and cortisol, the LH response to insulin-induced hypoglycemia was contrasted in saline and metyrapone pretreated monkeys. LH concentrations were reduced to approximately 40% of basal levels following insulin in both metyrapone and saline pretreated monkeys. Therefore, even though inhibition of cortisol synthesis leads to an increase in CRF messenger RNA in the paraventricular nucleus and a robust increase in ACTH secretion in rhesus monkeys, presumably due in part to increased neuroendocrine CRF secretion, LH secretion was not inhibited during either the acute or more chronic phase of corticotroph activation. Absence of LH inhibition was not due to low cortisol concentrations resulting from metyrapone because metyrapone did not prevent hypoglycemia-induced suppression of LH secretion. We conclude that increased neuroendocrine CRF secretion following metyrapone does not inhibit LH secretion under these conditions. Several explanations for this result are discussed.
引用
收藏
页码:2249 / 2258
页数:10
相关论文
共 43 条
[1]   THE ACUTE EFFECT OF LOWERING PLASMA-CORTISOL ON THE SECRETION OF CORTICOTROPIN-RELEASING HORMONE, ARGININE-VASOPRESSIN, AND ADRENOCORTICOTROPIN AS REVEALED BY INTENSIVE SAMPLING OF PITUITARY VENOUS-BLOOD IN THE NORMAL HORSE [J].
ALEXANDER, SL ;
IRVINE, CHG ;
LIVESEY, JH ;
DONALD, RA .
ENDOCRINOLOGY, 1993, 133 (02) :860-866
[2]   EVIDENCE FOR THE INVOLVEMENT OF ENDOGENOUS OPIOIDS IN THE INHIBITION OF LUTEINIZING-HORMONE BY CORTICOTROPIN-RELEASING FACTOR [J].
ALMEIDA, OFX ;
NIKOLARAKIS, KE ;
HERZ, A .
ENDOCRINOLOGY, 1988, 122 (03) :1034-1041
[3]   CRH GENE-EXPRESSION IN THE FETAL-RAT IS NOT INCREASED AFTER PHARMACOLOGICAL ADRENALECTOMY [J].
BARAM, TZ ;
SCHULTZ, L .
NEUROSCIENCE LETTERS, 1992, 142 (02) :215-218
[4]   CORTICOTROPIN-RELEASING HORMONE INHIBITION OF GONADOTROPIN-RELEASE AND THE EFFECT OF OPIOID BLOCKADE [J].
BARBARINO, A ;
DEMARINIS, L ;
TOFANI, A ;
DELLACASA, S ;
DAMICO, C ;
MANCINI, A ;
CORSELLO, SM ;
SCIUTO, R ;
BARINI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (03) :523-528
[5]   NEURO-ENDOCRINE ABERRATIONS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA [J].
BERGA, SL ;
MORTOLA, JF ;
GIRTON, L ;
SUH, B ;
LAUGHLIN, G ;
PHAM, P ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :301-308
[6]   ABNORMAL CORTISOL SECRETION AND RESPONSES TO CORTICOTROPIN-RELEASING HORMONE IN WOMEN WITH HYPOTHALAMIC AMENORRHEA [J].
BILLER, BMK ;
FEDEROFF, HJ ;
KOENIG, JI ;
KLIBANSKI, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (02) :311-317
[7]   CORTICOTROPIN-RELEASING FACTOR CAN STIMULATE GONADOTROPIN-SECRETION BY HUMAN-FETAL PITUITARIES IN SUPERFUSION [J].
BLUMENFELD, Z ;
KUHN, RW ;
JAFFE, RB .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (03) :606-612
[8]   CORTISOL SECRETION AND METABOLISM IN ANOREXIA-NERVOSA [J].
BOYAR, RM ;
HELLMAN, LD ;
ROFFWARG, H ;
KATZ, J ;
ZUMOFF, B ;
OCONNOR, J ;
BRADLOW, HL ;
FUKUSHIMA, DK .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (04) :190-193
[9]   INVOLVEMENT OF OVARIAN-STEROIDS AND ENDOGENOUS OPIOIDS IN THE FASTING-INDUCED SUPPRESSION OF PULSATILE LH-RELEASE IN OVARIECTOMIZED RATS [J].
CAGAMPANG, FRA ;
MAEDA, KI ;
TSUKAMURA, H ;
OHKURA, S ;
OTA, K .
JOURNAL OF ENDOCRINOLOGY, 1991, 129 (03) :321-328
[10]   HYPOGLYCEMIC STRESS AND GONADOTROPIN-RELEASING-HORMONE PULSE-GENERATOR ACTIVITY IN THE RHESUS-MONKEY - ROLE OF THE OVARY [J].
CHEN, MD ;
OBYRNE, KT ;
CHIAPPINI, SE ;
HOTCHKISS, J ;
KNOBIL, E .
NEUROENDOCRINOLOGY, 1992, 56 (05) :666-673